Gujarat Themis Biosyn Limited

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

N/A

Website

www.gtbl.in

Country

India

Exchange

NSE

Gujarat Themis Biosyn provides the manufacture of pharmaceuticals and medicinal chemicals in India and Japan. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease.

Its portfolio also includes Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy, and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.

Key Stats

52-Week Range

₹225.05₹479.00

Beta0.34

Trailing P/E82.96

Forward P/EN/A

Trailing EPS4.29

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.